MyFinsight
Home
Blog
About
Contact
Download
Download image
Investment in associate at
fair value
$102,299K
Investments at fair value
$50,678K
Investment in lifeward
$22,492K
Marketable securities
$17,967K
Other non-marketable
equity securities
$3,624K
Investment in real estate
$1,921K
Operating lease
right-of-use assets
$684K
Property and equipment,
net
$561K
Loan to an equity
method investee
$423K
Amounts funded in
respect of employee...
$46K
Long-term deposits
$2K
Investments at fair value
$36,576K
Cash and cash
equivalents
$13,202K
Short-term deposits
$11,097K
Marketable securities
$4,965K
Prepaid expenses and
other current assets
$2,310K
Total long-term
assets
$200,697K
Total current assets
$68,150K
Total assets
$268,847K
Total liabilities and
equity
$268,847K
Total equity
$238,276K
Total long-term
liabilities
$20,008K
Total current
liabilities
$10,563K
Accumulated deficit
-$85,121K
Additional paid-in capital
$322,906K
Deferred tax liabilities
$17,747K
Deferred income
$1,530K
Operating lease
liabilities
$493K
Dividend payable
$198K
Employee rights upon
retirement
$40K
Accounts payable and
accrued expenses
$8,521K
Deferred income
$1,471K
Dividend payable
$303K
Operating lease
liabilities
$268K
Common stock, 0.012 par
value (60,000,000...
$491K
Back
Back
Balance Sheet
source: myfinsight.com
ORAMED PHARMACEUTICALS INC. (ORMP)
ORAMED PHARMACEUTICALS INC. (ORMP)